Sage Journals: Discover world-class research

Abstract

Purpose

To describe a young male with bilateral sequential Cytomegalovirus retinitis (CMVR) as the presenting feature of Dyskeratosis Congenita

Case report

A 25-year-old human immunodeficiency virus (HIV) negative male developed CMVR in his left eye, while on a three week course of oral valganciclovir therapy for CMV retinitis in his right eye. Systemic examination revealed reticular hypopigmentation of the forearms, dystrophic nails, oral leukoplakia and complete blood counts showed pancytopenia. A diagnosis of Dyskeratosis Congenita was confirmed with genetic testing.

Conclusion

CMVR in non-HIV individuals should be considered as a harbinger of systemic immunosuppressive conditions. Ophthalmologists may be the first ones to suspect and diagnose congenital immunosuppressive disorders like Dyskeratosis Congenita in these patients.

Keywords

Cytomegalovirus retinitis CMV Dyskeratosis congenita

Get full access to this article

View all access options for this article.

References

Jabs

Van Natta

Holbrook

, et al. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology 2007; 114: 780–786.

Invernizzi

Zagora

, et al. Presenting features, treatment and clinical outcomes of cytomegalovirus retinitis: non-HIV patients vs HIV patients. Ocul Immunol Inflamm 2020; 28: 6541–6548.

Shapira

Mimouni

Vishnevskia-Dai

. Cytomegalovirus retinitis in HIV-negative patients - associated conditions, clinical presentation, diagnostic methods and treatment strategy. Acta Ophthalmol 2018; 96: e761–e767.

Dogra

Rohilla

Dogra

, et al. Macular cytomegalovirus retinitis following dexamethasone intravitreal implant combined with phacoemulsification. Indian J Ophthalmol 2018; 66: 1361–1363.

Sölder

Weiss

Jäger

, et al. Dyskeratosis congenita: multisystemic disorder with special consideration of immunologic aspects. A review of the literature. Clin Pediatr (Phila) 1998; 37: 521–530.

Fernández García

Teruya-Feldstein

. The diagnosis and treatment of dyskeratosis congenita: a review. J Blood Med 2014; 5: 157–167.

Niewisch

Savage

. An update on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Rev Hematol 2019; 12: 1037–1052.

Vaz-Pereira

Pacheco

Gandhi

, et al. Bilateral retinal vasculopathy associated with autosomal dominant dyskeratosis congenita. Eur J Ophthalmol 2013; 23: 772–775.

Johnson

Hatfield

Pulido

. Retinal vasculopathy in a family with autosomal dominant dyskeratosis congenita. Ophthalmic Genet 2009; 30: 181–184.

10.

Haug

Randhawa

, et al. Cytomegalovirus retinitis in dyskeratosis congenita. Retin Cases Brief Rep 2013; 7: 29–31.

11.

Parchand

Barwad

. Cytomegalovirus retinitis as a presenting feature of multisystem disorder: dyskeratosis congenita. Middle East Afr J Ophthalmol 2017; 24: 219–221.

12.

Fuente

Dokal

. Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation. Pediatr Transplant 2007; 11: 584–594.